We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

184 hedge funds and large institutions have $761M invested in Acorda Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 79 increasing their positions, 41 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 41

24% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 21

3% more funds holding

Funds holding: 179 → 184 (+5)

8% less capital invested

Capital invested by funds: $826M → $761M (-$65M)

52% less call options, than puts

Call options by funds: $2.4M | Put options by funds: $5.05M

Holders
184
Holders Change
+5
Holders Change %
+2.79%
% of All Funds
3.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
79
Reduced
41
Closed
21
Calls
$2.4M
Puts
$5.05M
Net Calls
-$2.65M
Net Calls Change
-$26M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$27.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$11.5M
3
State Street
State Street
Massachusetts
+$9.6M
4
Prudential Financial
Prudential Financial
New Jersey
+$6.06M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$5.08M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$17.3M
2
Invesco
Invesco
Georgia
-$17.1M
3
SCM
Scopia Capital Management
New York
-$15.5M
4
Millennium Management
Millennium Management
New York
-$11M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$4.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
Rafferty Asset Management
51
Rafferty Asset Management
New York
$1.99M +$2.25M +1,248 New
CSS
52
Cubist Systematic Strategies
Connecticut
$1.89M +$1.85M +1,027 +658%
BIM
53
Bogle Investment Management
Massachusetts
$1.78M +$2.01M +1,115 New
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$1.67M +$12.6K +7 +0.7%
PPA
55
Parametric Portfolio Associates
Washington
$1.58M -$9.01K -5 -0.5%
AA
56
ALPS Advisors
Colorado
$1.53M +$77.5K +43 +5%
SEI Investments
57
SEI Investments
Pennsylvania
$1.44M +$553K +307 +52%
Legal & General Group
58
Legal & General Group
United Kingdom
$1.39M +$135K +75 +9%
QI
59
QS Investors
New York
$1.36M – – –
Massachusetts Financial Services
60
Massachusetts Financial Services
Massachusetts
$1.28M +$54K +30 +4%
Wells Fargo
61
Wells Fargo
California
$1.25M +$247K +137 +21%
SFM
62
Systematic Financial Management
New Jersey
$1.21M +$364K +202 +36%
State of New Jersey Common Pension Fund D
63
State of New Jersey Common Pension Fund D
New Jersey
$1.2M – – –
3C
64
361 Capital
Colorado
$1.17M +$1.32M +733 New
BPM
65
Bowling Portfolio Management
Ohio
$1.12M -$3.6K -2 -0.3%
PAM
66
Panagora Asset Management
Massachusetts
$1.08M -$189K -105 -13%
Morgan Stanley
67
Morgan Stanley
New York
$1.06M +$123K +68 +11%
CAM
68
ClariVest Asset Management
California
$1.06M -$93.7K -52 -7%
Ohio Public Employees Retirement System (OPERS)
69
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.04M +$847K +470 +257%
Adage Capital Partners
70
Adage Capital Partners
Massachusetts
$997K +$1.13M +625 New
AllianceBernstein
71
AllianceBernstein
Tennessee
$953K – – –
Swiss National Bank
72
Swiss National Bank
Switzerland
$921K +$32.4K +18 +3%
California State Teachers Retirement System (CalSTRS)
73
California State Teachers Retirement System (CalSTRS)
California
$907K – – –
New York State Common Retirement Fund
74
New York State Common Retirement Fund
New York
$891K -$63.1K -35 -6%
UBS Group
75
UBS Group
Switzerland
$887K -$1.36M -755 -58%
1 2
3
4 5

ACOR Hedge Fund Activity: Q1 2019 in Review

184 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q1 2019, worth a combined $761M — down 7.9% from $826M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ACOR positions and 21 closed out — a net gain of 5 holders — while 79 added to existing stakes and 41 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $27.4M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $17.3M sold.

  • 184 institutional investors held Acorda Therapeutics (ACOR) as of Q1 2019, up from 179 in Q4 2018.
  • Funds reported $761M of Acorda Therapeutics stock for Q1 2019, down 7.9% quarter-over-quarter.
  • 26 funds opened new Acorda Therapeutics positions in Q1 2019 and 21 closed out, a net change of +5 holders.
  • The largest Acorda Therapeutics buyer in Q1 2019 was Renaissance Technologies, an estimated $27.4M added.
  • The largest Acorda Therapeutics seller in Q1 2019 was PFM Health Sciences, an estimated $17.3M sold.

Based on aggregated 13F filings for Q1 2019.